Oncternal Therapeutics, Inc. (ONCT)
NASDAQ: ONCT · IEX Real-Time Price · USD
7.00
-0.08 (-1.13%)
Jul 19, 2024, 4:00 PM EDT - Market closed
Oncternal Therapeutics Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for ONCT stock have an average target of 28.33, with a low estimate of 19 and a high estimate of 40. The average target predicts an increase of 304.71% from the current stock price of 7.00.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for ONCT stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 3 | 3 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $19 | Strong Buy | Reiterates | $19 | +171.43% | Jul 16, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $19 | Strong Buy | Reiterates | $19 | +171.43% | May 31, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $28 → $19 | Strong Buy | Maintains | $28 → $19 | +171.43% | May 13, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $30 → $28 | Strong Buy | Maintains | $30 → $28 | +300.00% | Apr 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $2 → $30 | Strong Buy | Maintains | $2 → $30 | +328.57% | Jan 29, 2024 |
Financial Forecast
Revenue This Year
1.22M
from 785.00K
Increased by 55.67%
Revenue Next Year
816.00K
from 1.22M
Decreased by -33.22%
EPS This Year
-10.81
from -13.43
EPS Next Year
-9.79
from -10.81
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 1.5M | 1.1M | 1.1M |
| Avg | 1.2M | 816,000 | 1.0M |
| Low | 980,000 | 588,000 | 980,000 |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 86.5% | -14.1% | 28.7% |
| Avg | 55.7% | -33.2% | 25.0% |
| Low | 24.8% | -51.9% | 20.1% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -8.65 | -9.02 | -6.47 |
| Avg | -10.81 | -9.79 | -6.28 |
| Low | -12.34 | -10.05 | -6.04 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.